Tanyalak Parimon
Internal Medicine · Cedars-Sinai Medical Center
Credentials: · · ·
History
1996–1998- 1993–1996
Internal Medicine
Research
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection
JAMA · 2023 · 730 citations
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine · 2021 · 431 citations
Alveolar Epithelial Type II Cells as Drivers of Lung Fibrosis in Idiopathic Pulmonary Fibrosis
Review · International Journal of Molecular Sciences · 2020 · First of 5 authors · Corresponding · 318 citations
36 papers
- PN
12 papers
7 papers
- JC
4 papers
4 papers
- AA
3 papers
3 papers
3 papers
Grants
- 2026–2031
Viral-Mediated Immunological Niche Facilitates Lung Fibrosis
National Heart, Lung, and Blood Institute · P01
Project lead · $389.2K · Cedars-Sinai Medical Center
- 2020–2025
Syndecan-1 Regulation of Lung Fibrosis
National Heart, Lung, and Blood Institute · K08
Contact PI · $853.7K · Cedars-Sinai Medical Center
Identification and Dynamics of SARS-CoV-2 Sequence Variants in Idaho
National Institute of General Medical Sciences · P20
Project lead · $1.1M · Idaho Veterans Research / Education Fdn